EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting intratumoral hypoxia to enhance anti-tumor immunity

Gregg L Semenza

Seminars in Cancer Biology · 2023-11 · 96 · 5-10

DOI: 10.1016/j.semcancer.2023.09.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2023-11. Verfasst von Gregg L Semenza. Beteiligte Einrichtung: Department of Genetic Medicine, Institute for Cell Engineering, and Armstrong Oxygen Biology Research Center, Johns Hopkins University School of Medi…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 82 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsMaleHumansHypoxiaTumor Microenvironment

Stichwörter der Autor:innen

Hypoxia-inducible factorImmune checkpoint inhibitorImmune evasionImmunotherapyIntratumoral hypoxia

Autor:innen und Institutionen

  • Department of Genetic Medicine, Institute for Cell Engineering, and Armstrong Oxygen Biology Research Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Electronic address: gsemenza@jhmi.edu.

Zitieren

APA

Semenza, G. L. (2023). Targeting intratumoral hypoxia to enhance anti-tumor immunity. Seminars in Cancer Biology, 96, 5-10. https://doi.org/10.1016/j.semcancer.2023.09.002

Vancouver

Semenza GL. Targeting intratumoral hypoxia to enhance anti-tumor immunity. Seminars in Cancer Biology. 2023;96:5-10. doi:10.1016/j.semcancer.2023.09.002

BibTeX
@article{Semenza2023,
  author = {Semenza, Gregg L},
  title = {Targeting intratumoral hypoxia to enhance anti-tumor immunity},
  journal = {Seminars in Cancer Biology},
  year = {2023},
  volume = {96},
  pages = {5--10},
  doi = {10.1016/j.semcancer.2023.09.002}
}
Kostenlos starten →